Fresenius Medical Care AG (NYSE:FMS) Short Interest Down 6.4% in November

Fresenius Medical Care AG (NYSE:FMS) was the recipient of a significant decrease in short interest during the month of November. As of November 30th, there was short interest totalling 852,500 shares, a decrease of 6.4% from the November 15th total of 910,900 shares. Based on an average daily volume of 277,600 shares, the days-to-cover ratio is presently 3.1 days.

Fresenius Medical Care Stock Down 0.8 %

Fresenius Medical Care stock traded down $0.20 during trading hours on Tuesday, hitting $23.61. 235,437 shares of the stock traded hands, compared to its average volume of 353,149. The firm’s 50-day moving average price is $21.58 and its two-hundred day moving average price is $20.48. The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42. The company has a market cap of $13.85 billion, a PE ratio of 19.69, a PEG ratio of 0.96 and a beta of 0.94. Fresenius Medical Care has a one year low of $17.93 and a one year high of $24.31.

Institutional Trading of Fresenius Medical Care

Hedge funds have recently made changes to their positions in the stock. Allworth Financial LP boosted its position in shares of Fresenius Medical Care by 53.1% in the 3rd quarter. Allworth Financial LP now owns 1,675 shares of the company’s stock worth $36,000 after purchasing an additional 581 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in Fresenius Medical Care during the 3rd quarter valued at $38,000. GAMMA Investing LLC raised its stake in Fresenius Medical Care by 50.4% during the 3rd quarter. GAMMA Investing LLC now owns 4,998 shares of the company’s stock valued at $106,000 after buying an additional 1,675 shares during the last quarter. ORG Wealth Partners LLC purchased a new stake in shares of Fresenius Medical Care in the 3rd quarter worth $112,000. Finally, Venturi Wealth Management LLC increased its stake in shares of Fresenius Medical Care by 1,045.8% in the 3rd quarter. Venturi Wealth Management LLC now owns 5,259 shares of the company’s stock worth $112,000 after purchasing an additional 4,800 shares in the last quarter. 8.37% of the stock is owned by institutional investors.

Analysts Set New Price Targets

FMS has been the subject of a number of analyst reports. Berenberg Bank initiated coverage on Fresenius Medical Care in a report on Wednesday, November 6th. They issued a “buy” rating and a $25.60 price target for the company. StockNews.com assumed coverage on Fresenius Medical Care in a report on Thursday, November 28th. They set a “strong-buy” rating on the stock. Bank of America upgraded Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a report on Monday, December 2nd. Finally, Truist Financial boosted their price target on Fresenius Medical Care from $22.00 to $23.00 and gave the company a “hold” rating in a report on Monday, October 7th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, one has given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $24.30.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.